• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
High Adenoma Detection Rates in Fecal Immunochemical Test-Based Colorectal Cancer Screening: Interim Results of the National Bowel Cancer Screening Program in Qatar.基于粪便免疫化学检测的结直肠癌筛查中腺瘤高检出率:卡塔尔国家肠癌筛查计划的中期结果
Cureus. 2022 Dec 6;14(12):e32274. doi: 10.7759/cureus.32274. eCollection 2022 Dec.
2
The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design.多靶点粪便免疫化学试验与粪便免疫化学试验用于结直肠癌筛查项目:一项具有配对设计的横断面干预研究。
BMC Cancer. 2022 Dec 12;22(1):1299. doi: 10.1186/s12885-022-10372-2.
3
Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.用于结直肠癌筛查的粪便潜血试验:一项基于证据的分析。
Ont Health Technol Assess Ser. 2009;9(10):1-40. Epub 2009 Sep 1.
4
Colorectal cancer screening with fecal immunochemical testing: a community-based, cross-sectional study in average-risk individuals in Nigeria.粪便免疫化学检测在尼日利亚普通风险人群中的结直肠癌筛查:一项基于社区的横断面研究。
Lancet Glob Health. 2022 Jul;10(7):e1012-e1022. doi: 10.1016/S2214-109X(22)00121-8.
5
[Efficacy comparison among high risk factors questionnaire and Asia-Pacific colorectal screening score and their combinations with fecal immunochemical test in screening advanced colorectal tumor].[高危因素问卷与亚太地区结直肠癌筛查评分及其与粪便免疫化学检测联合应用在筛查进展期结直肠癌中的效果比较]
Zhonghua Wei Chang Wai Ke Za Zhi. 2022 Jul 25;25(7):612-620. doi: 10.3760/cma.j.cn441530-20211127-00478.
6
Application of fecal immunochemical test in colorectal cancer screening: A community-based, cross-sectional study in average-risk individuals in Hainan.粪便免疫化学检测在结直肠癌筛查中的应用:一项基于海南普通风险人群的社区横断面研究。
World J Gastrointest Oncol. 2024 Aug 15;16(8):3445-3456. doi: 10.4251/wjgo.v16.i8.3445.
7
Diagnostic Yield of One-Time Colonoscopy vs One-Time Flexible Sigmoidoscopy vs Multiple Rounds of Mailed Fecal Immunohistochemical Tests in Colorectal Cancer Screening.在结直肠癌筛查中,一次性结肠镜检查与一次性乙状结肠镜检查和多次邮寄粪便免疫化学检测的诊断收益比较。
Clin Gastroenterol Hepatol. 2020 Mar;18(3):667-675.e1. doi: 10.1016/j.cgh.2019.08.015. Epub 2019 Aug 13.
8
Performance of a quantitative fecal immunochemical test in a colorectal cancer screening pilot program: a prospective cohort study.一项结直肠癌筛查试点项目中定量粪便免疫化学检测的性能:一项前瞻性队列研究。
CMAJ Open. 2016 Nov 4;4(4):E668-E673. doi: 10.9778/cmajo.20160047. eCollection 2016 Oct-Dec.
9
Colorectal cancer detection in an asymptomatic population: fecal immunochemical test for hemoglobin vs. fecal M2-type pyruvate kinase.无症状人群中的结直肠癌检测:血红蛋白粪便免疫化学检测与粪便M2型丙酮酸激酶检测的比较
Biochem Med (Zagreb). 2016;26(1):114-20. doi: 10.11613/BM.2016.012.
10

引用本文的文献

1
Screening, awareness and challenges for colorectal cancer treatment in Saudi Arabia: an update.沙特阿拉伯结直肠癌治疗的筛查、认知及挑战:最新进展
Bioinformation. 2024 Apr 30;20(4):397-403. doi: 10.6026/973206300200397. eCollection 2024.

本文引用的文献

1
ACG Clinical Guidelines: Colorectal Cancer Screening 2021.ACG 临床指南:结直肠癌筛查 2021 年版。
Am J Gastroenterol. 2021 Mar 1;116(3):458-479. doi: 10.14309/ajg.0000000000001122.
2
Occurrence and characteristics of faecal immunochemical screen-detected cancers vs non-screen-detected cancers: Results from a Flemish colorectal cancer screening programme.粪便免疫化学筛查检测出的癌症与非筛查检测出的癌症的发生率及特征:来自佛兰德结直肠癌筛查项目的结果
United European Gastroenterol J. 2020 Mar;8(2):185-194. doi: 10.1177/2050640619882157. Epub 2019 Oct 3.
3
Colorectal cancer population screening programs worldwide in 2016: An update.2016 年全球结直肠癌人群筛查计划:更新。
World J Gastroenterol. 2017 May 28;23(20):3632-3642. doi: 10.3748/wjg.v23.i20.3632.
4
Cancer screening uptake: association with individual characteristics, geographic distribution, and time trends in Italy.癌症筛查的接受情况:与意大利的个体特征、地理分布及时间趋势的关联
Epidemiol Prev. 2015 May-Jun;39(3 Suppl 1):9-18.
5
The Global Burden of Cancer 2013.《2013 年全球癌症负担》。
JAMA Oncol. 2015 Jul;1(4):505-27. doi: 10.1001/jamaoncol.2015.0735.
6
Colorectal cancer screening: a global overview of existing programmes.结直肠癌筛查:现有项目的全球概览。
Gut. 2015 Oct;64(10):1637-49. doi: 10.1136/gutjnl-2014-309086. Epub 2015 Jun 3.
7
Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know.粪便免疫化学试验与愈创木脂粪便潜血试验:临床医生和结直肠癌筛查计划组织者需要了解的内容。
Gut. 2015 Aug;64(8):1327-37. doi: 10.1136/gutjnl-2014-308074. Epub 2015 Jun 3.
8
Quality indicators for colonoscopy.结肠镜检查的质量指标。
Gastrointest Endosc. 2015 Jan;81(1):31-53. doi: 10.1016/j.gie.2014.07.058. Epub 2014 Dec 2.
9
Emerging role for colorectal cancer screening in Asian countries.结直肠癌筛查在亚洲国家的新作用。
Trop Gastroenterol. 2014 Jan-Mar;35(1):21-4. doi: 10.7869/tg.159.
10
Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).免疫化学粪便潜血试验在结直肠癌筛查项目中结肠镜检查的质量:EQuIPE 研究(评估内镜性能质量指标)。
Gut. 2015 Sep;64(9):1389-96. doi: 10.1136/gutjnl-2014-307954. Epub 2014 Sep 16.

基于粪便免疫化学检测的结直肠癌筛查中腺瘤高检出率:卡塔尔国家肠癌筛查计划的中期结果

High Adenoma Detection Rates in Fecal Immunochemical Test-Based Colorectal Cancer Screening: Interim Results of the National Bowel Cancer Screening Program in Qatar.

作者信息

John Anil K, Varughese Betsy, Abushaikha Shaikha S, Hamdan Ahed M, Pillai Viswapriya, Ayash Ahmad M, Vincent Paul K, Sultan Khaleel, Al Ejji Khalid M, Singh Rajvir, Alabdulla Samya, Abdulmalik Mariam, Al Kaabi Saad

机构信息

Gastroenterology and Hepatology, Hamad Medical Corporation, Doha, QAT.

Community Medicine, Primary Health Care Corporation, Doha, QAT.

出版信息

Cureus. 2022 Dec 6;14(12):e32274. doi: 10.7759/cureus.32274. eCollection 2022 Dec.

DOI:10.7759/cureus.32274
PMID:36628034
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9822526/
Abstract

INTRODUCTION

Colorectal cancer is one of the most common cancers globally. Recent reductions in mortality rates have been primarily attributed to screening programs. The State of Qatar established a national bowel cancer screening program in 2016.

METHODOLOGY

Fecal immunochemical testing (FIT) was used for average-risk individuals aged 50 to 74 years. Fecal immunochemical testing -positive participants were referred for total colonoscopy to detect polyps and cancers.

RESULTS

Among 32,751 FIT invitees, 11,130 took the test, and 758 (6%) of those were FIT positive. Of these, 375 (56.13%) participants underwent a colonoscopy, and polyps were detected in 198 (52.8%) and cancers in 19 (5.1%) participants. The adenoma detection rate exceeded 40%.

DISCUSSION AND CONCLUSION

The high yield of polyps and cancers in the screening program justifies an active, resource-intensive, and organized bowel cancer screening effort. The high adenoma detection rate in a FIT-based program warrants recalibration of target adenoma detection rates in screening programs.

摘要

引言

结直肠癌是全球最常见的癌症之一。近期死亡率的下降主要归功于筛查项目。卡塔尔国于2016年设立了全国性的肠癌筛查项目。

方法

对50至74岁的平均风险个体采用粪便免疫化学检测(FIT)。粪便免疫化学检测呈阳性的参与者被转诊进行全结肠镜检查以检测息肉和癌症。

结果

在32751名收到FIT检测邀请的人中,11130人接受了检测,其中758人(6%)FIT呈阳性。在这些人中,375名(56.13%)参与者接受了结肠镜检查,198名(52.8%)参与者检测出息肉,19名(5.1%)参与者检测出癌症。腺瘤检出率超过40%。

讨论与结论

筛查项目中息肉和癌症的高检出率证明了积极、资源密集且有组织的肠癌筛查工作是合理的。基于FIT的项目中的高腺瘤检出率需要重新校准筛查项目中的目标腺瘤检出率。